Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
Use of Microtubule Destabilizers for Improving Oncolytic Virotherapy
FY 2013-14
Summary
Cancer is a disease that affects many Canadians. Although progress is being made in the treatment of this complex disease, the improvement of current therapies is vital. Currently, chemotherapy is the standard course of treatment, but unfortunately it is a highly toxic regiment. It not only targets the tumour, but also harms normal tissue leading to unwanted and sometimes severe secondary side effects. A more recent approach has been the used of cancer-targeting viruses. These viruses have been shown to specifically target tumour cells while leaving normal cells unharmed, thus restricting tissue damage and side effects. Cancer-targeting viruses have been used successfully to target various tumour types, which has led to several ongoing clinical trials. However, some tumours are inherently resistant to viral infection. Our approach is through the engineering a novel cancer-targeting virus which would be equipped with a gene to further disrupt tumour cell growth. This gene would be expressed by the virus and aid in its spread throughout the tumour. We are confident that would improve the current cancer-targeting viruses since a greater number of tumour types could be targeted. The specificity of the treatment would also minimize the unwanted side effects associated to chemotherapy while improving virus delivery to the tumour site.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
311776
Name
Garcia Vanessa L
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Use of Microtubule Destabilizers for Improving Oncolytic Virotherapy
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bacterial Gene Products; Cancer; Microtubule Destabilizers; Oncolytic Viruses
Abstract
Cancer is a disease that affects many Canadians. Although progress is being made in the treatment of this complex disease, the improvement of current therapies is vital. Currently, chemotherapy is the standard course of treatment, but unfortunately it is a highly toxic regiment. It not only targets the tumour, but also harms normal tissue leading to unwanted and sometimes severe secondary side effects. A more recent approach has been the used of cancer-targeting viruses. These viruses have been shown to specifically target tumour cells while leaving normal cells unharmed, thus restricting tissue damage and side effects. Cancer-targeting viruses have been used successfully to target various tumour types, which has led to several ongoing clinical trials. However, some tumours are inherently resistant to viral infection. Our approach is through the engineering a novel cancer-targeting virus which would be equipped with a gene to further disrupt tumour cell growth. This gene would be expressed by the virus and aid in its spread throughout the tumour. We are confident that would improve the current cancer-targeting viruses since a greater number of tumour types could be targeted. The specificity of the treatment would also minimize the unwanted side effects associated to chemotherapy while improving virus delivery to the tumour site.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Garcia, Vanessa L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~